百济神州：Growing non-GAAP profit

14 Nov 2024 CMB International Global Markets | Equity Research | Company Update BeiGene (BGNE US) Growing non-GAAP profit ■ Strong product sales. In 3Q24, BeiGene recorded product sales of US$993mn (+8% QoQ, +67% YoY). The 9M24 total product sales reached US$2.66bn, representing 69% of our previous FY24 estimate. In 3Q24, sales of zanubrutinib (Zanu) increased 8% QoQ or 93% Yo Y to US$690mn. The growth rate in Q3 was notably slower compared to the 30% QoQ increase in Q2, primarily due to a one- off sales or ...